CKD-828 (80/5mg) Pharmacokinetic Study

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

May 31, 2015

Study Completion Date

June 30, 2015

Conditions
Hypertension
Interventions
DRUG

CKD-828

"Telmisartan 80mg /S-Amlodipine 5mg(FDC) Tablet, Oral, Once Daily~(1arm:2period and 4period, 2arm:1period and 3period)"

DRUG

Telmisartan

"\- Telmisartan 80mg tablet, Oral, Once Daily (Combination Therapy with S-amlodipine)~(1arm:1period and 3period, 2arm: 2period and 4period)"

DRUG

S-amlodipine

"\- S-amlodipine 5mg tablet, Oral, Once Daily (combination Therapy with Telmisartan)~(1arm:1period and 3period, 2arm: 2period and 4period)"

Trial Locations (1)

700-721

Kyungpook National University Hospital, Daegu, Samdeok-dong, 2-ga 50

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY

NCT02358824 - CKD-828 (80/5mg) Pharmacokinetic Study | Biotech Hunter | Biotech Hunter